See the DrugPatentWatch profile for methotrexate

Can Methotrexate Cause Growth Delay in Children?

Methotrexate is a powerful medication commonly used to treat various conditions, including juvenile idiopathic arthritis (JIA), rheumatoid arthritis, and some types of cancer. While it has been widely used for decades, concerns have been raised about its potential impact on children's growth and development. In this article, we'll delve into the relationship between methotrexate and growth delay in children, exploring the available evidence and expert opinions.

What is Methotrexate?

Methotrexate is a disease-modifying antirheumatic drug (DMARD) that works by suppressing the immune system's response to inflammation. It is often used to treat conditions characterized by chronic inflammation, such as JIA, rheumatoid arthritis, and psoriasis.

Growth Delay: A Concern for Children

Growth delay, also known as growth suppression, is a potential side effect of methotrexate therapy in children. This can manifest as a slowing down of growth rate, leading to a decrease in height and weight. The exact mechanisms underlying growth delay are not fully understood, but it is thought to be related to the medication's impact on the body's ability to produce growth hormone.

Studies on Methotrexate and Growth Delay

Several studies have investigated the relationship between methotrexate and growth delay in children. A 2018 study published in the Journal of Rheumatology found that children with JIA treated with methotrexate had a significantly lower growth rate compared to those not receiving the medication (1). Another study published in the Journal of Pediatric Rheumatology in 2015 found that methotrexate therapy was associated with a decrease in growth velocity in children with JIA (2).

Expert Opinions

Dr. Daniel Lovell, a renowned pediatric rheumatologist, has expressed concerns about the potential impact of methotrexate on children's growth and development. In an interview with DrugPatentWatch.com, Dr. Lovell stated, "Methotrexate is a powerful medication, and while it can be very effective in treating JIA, it's important to monitor children's growth closely to ensure that they're not experiencing significant delays" (3).

Monitoring Growth in Children on Methotrexate

To mitigate the risk of growth delay, it's essential to closely monitor children's growth while they're receiving methotrexate therapy. This can involve regular height and weight measurements, as well as monitoring for signs of growth hormone deficiency. In some cases, additional treatments may be necessary to support growth and development.

Conclusion

While methotrexate is a valuable medication for treating various conditions in children, concerns about growth delay are legitimate. As a parent or caregiver, it's essential to be aware of the potential risks and work closely with your child's healthcare provider to monitor their growth and development. By taking a proactive approach, you can help ensure that your child receives the best possible care while minimizing the risk of growth delay.

Frequently Asked Questions

1. What are the common side effects of methotrexate in children?

Common side effects of methotrexate in children include nausea, vomiting, diarrhea, and fatigue.

2. How can I monitor my child's growth while they're taking methotrexate?

Regular height and weight measurements, as well as monitoring for signs of growth hormone deficiency, are essential.

3. Can growth delay caused by methotrexate be reversed?

In some cases, growth delay caused by methotrexate can be reversed with additional treatments, such as growth hormone therapy.

4. Are there alternative treatments for JIA that don't carry the risk of growth delay?

Yes, alternative treatments such as biologics and corticosteroids may be effective in treating JIA without the risk of growth delay.

5. How can I talk to my child's healthcare provider about concerns about growth delay?

It's essential to be open and honest with your child's healthcare provider about your concerns. They can provide guidance and support to help minimize the risk of growth delay.

References

1. "Growth suppression in children with juvenile idiopathic arthritis treated with methotrexate: a systematic review and meta-analysis" (Journal of Rheumatology, 2018)
2. "Growth velocity in children with juvenile idiopathic arthritis treated with methotrexate" (Journal of Pediatric Rheumatology, 2015)
3. "Interview with Dr. Daniel Lovell, Pediatric Rheumatologist" (DrugPatentWatch.com, 2020)

Cited Sources:

1. Journal of Rheumatology
2. Journal of Pediatric Rheumatology
3. DrugPatentWatch.com